We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Treatment of Late Abortion: Evacuatio Uteri or Conservative Treatment

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified November 2005 by Rigshospitalet, Denmark.
Recruitment status was:  Not yet recruiting
Sponsor:
ClinicalTrials.gov Identifier:
NCT00256009
First Posted: November 21, 2005
Last Update Posted: June 1, 2006
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
Rigshospitalet, Denmark
  Purpose
A randomize trial: expectation or evacuatio uteri for the treatment after late abortion

Condition Intervention Phase
Abortion, Spontaneous Abortion, Induced Drug: Cytotec Phase 4

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Evacuatio Uteri or Conservtive Treatment After Late Abortion. A Randomize Trial.

Resource links provided by NLM:


Further study details as provided by Rigshospitalet, Denmark:

Primary Outcome Measures:
  • Side-effect
  • Complication

Secondary Outcome Measures:
  • Quality of life

Estimated Enrollment: 200
Estimated Study Completion Date: January 2009
Detailed Description:
A randomize trial adressing 200 women consecutively recruited from clinical practice at Rigshospitalet.Expectation: administration of 800 microgram Cytotec half an hour after delivery. Surgery: Evacuation of the uterus
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 60 Years   (Adult)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

abortion at gestational age (ultrasound) 14+0 - 20+0

Exclusion Criteria:

Allergy to cytotec

  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00256009


Contacts
Contact: Lars Alling Møller, Md phd 0045 35451338 Lars.Alling@rh.dk

Sponsors and Collaborators
Rigshospitalet, Denmark
Investigators
Principal Investigator: Lars Alling Møller, MD phd Rigshospitalet, Denmark
  More Information

ClinicalTrials.gov Identifier: NCT00256009     History of Changes
Other Study ID Numbers: KF 01 279545
First Submitted: November 18, 2005
First Posted: November 21, 2005
Last Update Posted: June 1, 2006
Last Verified: November 2005

Keywords provided by Rigshospitalet, Denmark:
Late abortion

Additional relevant MeSH terms:
Abortion, Spontaneous
Pregnancy Complications
Misoprostol
Abortifacient Agents, Nonsteroidal
Abortifacient Agents
Reproductive Control Agents
Physiological Effects of Drugs
Anti-Ulcer Agents
Gastrointestinal Agents
Oxytocics